ARTICLE | Clinical News
Munich starts Phase II cancer trials
January 20, 2004 8:00 AM UTC
Munich Biotech (Neuried, Germany) began two open label, European Phase II trials of MBT-0206 in about 50 advanced metastatic breast cancer patients and about 70 metastatic pancreatic cancer patients. ...